Our secondary aims were to: (1) determine an association between CTCs and HCC stages and aggressive features of HCC; and (2) determine the association between CTCs in combination with AFP as a predictor for survival of HCC patients. The gene discussed is AFP; the disease is hepatocellular carcinoma.